John Maraganore - 18 Mar 2026 Form 3 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Role
Director
Signature
/s/ Max Heuer, by power of attorney, for John Maraganore
Issuer symbol
TAK
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 06:11:15 UTC
Previous filing
26 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MARAGANORE JOHN Director 75 SIDNEY STREET, CAMBRIDGE /s/ Max Heuer, by power of attorney, for John Maraganore 18 Mar 2026 0001180432

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TAK American Depositary Shares 7,600 18 Mar 2026 Direct
holding TAK Ordinary Shares 9,700 18 Mar 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 1,152 Direct F2
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 1,192 Direct F2
holding TAK Tax Obligation Award 18 Mar 2026 Ordinary Shares 1,180 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 shares), June 1, 2027 (3,400 shares) and June 1, 2028 (3,200 shares).
F2 Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Remarks:

Exhibit 24 Power of Attorney